Cryptogenic stroke

New England Journal of Medicine

Volumn 374, Issue 21, 2016, Pages 2065-2074

  Saver, Jeffrey L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL FIBRILLATION; BRAIN ISCHEMIA; COMPLICATION; DIFFERENTIAL DIAGNOSIS; HUMAN; MALE; MIDDLE AGED; PATENT FORAMEN OVALE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; STROKE; THROMBOEMBOLISM;

ATRIAL FIBRILLATION; BRAIN ISCHEMIA; DIAGNOSIS, DIFFERENTIAL; FORAMEN OVALE, PATENT; HUMANS; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; PRACTICE GUIDELINES AS TOPIC; STROKE; THROMBOEMBOLISM;

EID: 84971350663     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp1503946     Document Type: Article

References (54)

1. Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989; 25: 382-90.
2. Li L, Yiin GS, Geraghty OC, et al. Incidence, outcome, risk factors, and longterm prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol 2015; 14: 903-13.
3. Ji R, Schwamm LH, Pervez MA, Singhal AB. Ischemic stroke and transient ischemic attack in young adults: risk factors, diagnostic yield, neuroimaging, and thrombolysis. JAMA Neurol 2013; 70: 51-7.
4. Wolf ME, Grittner U, Böttcher T, Norrving B, Rolfs A, Hennerici MG. Phenotypic ASCO characterisation of young patients with ischemic stroke in the prospective multicentre observational sifap1 study. Cerebrovasc Dis 2015; 40: 129-35.
5. Bogousslavsky J, Caplan LR, eds. Uncommon causes of stroke. 2nd ed. Cambridge, United Kingdom: Cambridge University Press, 2008.
6. Saver JL, Tamburi T. Genetics of cerebrovascular disease. In: Pulst S-M, ed. Neurogenetics. Oxford, United Kingdom: Oxford University Press, 1999: 403-31.
7. Hart RG, Diener HC, Coutts SB, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 2014; 13: 429-38.
8. Paciaroni M, Agnelli G, Caso V, et al. Atrial fibrillation in patients with firstever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome. J Thromb Haemost 2005; 3: 1218-23.
9. Freilinger TM, Schindler A, Schmidt C, et al. Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke. JACC Cardiovasc Imaging 2012; 5: 397-405.
10. Scullen TA, Monlezun DJ, Siegler JE, et al. Cryptogenic stroke: clinical consideration of a heterogeneous ischemic subtype. J Stroke Cerebrovasc Dis 2015; 24: 993-9.
11. Mas J-L, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345: 1740-6.
12. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002; 105: 2625-31.
13. Bang OY, Lee PH, Joo SY, Lee JS, Joo IS, Huh K. Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Ann Neurol 2003; 54: 227-34.
14. Knebel F, Masuhr F, von Hausen W, et al. Transesophageal echocardiography in patients with cryptogenic cerebral ischemia. Cardiovasc Ultrasound 2009; 7: 15.
15. Rus Mansilla C, Mesa Rubio D, Suárez de Lezo Cruz Conde J, Rodríguez Almodovar A, Durán Torralbo C, Delgado Ortega M. Utility of transesophageal echocardiography in young patients with cryptogenic stroke and low cardiovascular risk. Med Clin (Barc) 2008; 130: 241-5. (In Spanish.)
16. Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 2013; 368: 1092-100.
17. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial-TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
18. Lee LJ, Kidwell CS, Alger J, Starkman S, Saver JL. Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 2000; 31: 1081-9.
19. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Wolf ME, Hennerici MG. The ASCOD phenotyping of ischemic stroke (updated ASCO phenotyping). Cerebrovasc Dis 2013; 36: 1-5.
20. Arsava EM, Ballabio E, Benner T, et al. The Causative Classification of Stroke system: an international reliability and optimization study. Neurology 2010; 75: 1277-84.
21. Marnane M, Duggan CA, Sheehan OC, et al. Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin Population Stroke Study. Stroke 2010; 41: 1579-86.
22. Chatzikonstantinou A, Wolf ME, Hennerici MG. Ischemic stroke in young adults: classification and risk factors. J Neurol 2012; 259: 653-9.
23. Sposato LA, Cipriano LE, Saposnik G, Ruíz Vargas E, Riccio PM, Hachinski V. Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2015; 14: 377-87.
24. Lazzaro MA, Krishnan K, Prabhakaran S. Detection of atrial fibrillation with concurrent Holter monitoring and continuous cardiac telemetry following ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis 2012; 21: 89-93.
25. Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012; 366: 120-9.
26. Boriani G, Glotzer TV, Santini M, et al. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J 2014; 35: 508-16.
27. Sanna T, Diener H-C, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014; 370: 2478-86.
28. Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 2014; 370: 2467-77.
29. Favilla CG, Ingala E, Jara J, et al. Predictors of finding occult atrial fibrillation after cryptogenic stroke. Stroke 2015; 46: 1210-5.
30. Suzuki S, Sagara K, Otsuka T, et al. Usefulness of frequent supraventricular extrasystoles and a high CHADS2 score to predict first-time appearance of atrial fibrillation. Am J Cardiol 2013; 111: 1602-7.
31. Chiti A, Giannini N, Terni E, et al. "Cardioembolic profile" in patients with ischemic stroke: data from the analysis of 1037 cases. J Stroke Cerebrovasc Dis 2015; 24: 1287-90.
32. Kamel H, Okin PM, Longstreth WT Jr, Elkind MS, Soliman EZ. Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation. Future Cardiol 2015; 11: 323-31.
33. Yaghi S, Moon YP, Mora-McLaughlin C, et al. Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study. Stroke 2015; 46: 1488-93.
34. Taina M, Vanninen R, Hedman M, et al. Left atrial appendage volume increased in more than half of patients with cryptogenic stroke. PLoS One 2013; 8(11): e79519.
35. Korhonen M, Muuronen A, Arponen O, et al. Left atrial appendage morphology in patients with suspected cardiogenic stroke without known atrial fibrillation. PLoS One 2015; 10(3): e0118822.
36. Acampa M, Guideri F, Tassi R, et al. P wave dispersion in cryptogenic stroke: a risk factor for cardioembolism? Int J Cardiol 2015; 190: 202-4.
37. Martin DT, Bersohn MM, Waldo AL, et al. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J 2015; 36: 1660-8.
38. Saver JL. Cryptogenic stroke in patients with patent foramen ovale. Curr Atheroscler Rep 2007; 9: 319-25.
39. Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke 2009; 40: 2349-55.
40. Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 2013; 81: 619-25.
41. Ozdemir AO, Tamayo A, Munoz C, Dias B, Spence JD. Cryptogenic stroke and patent foramen ovale: clinical clues to paradoxical embolism. J Neurol Sci 2008; 275: 121-7.
42. Cramer SC, Rordorf G, Maki JH, et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke 2004; 35: 46-50.
43. Huang YY, Shao B, Ni XD, Li JC. Differential lesion patterns on T2-weighted magnetic resonance imaging and fluidattenuated inversion recovery sequences in cryptogenic stroke patients with patent foramen ovale. J Stroke Cerebrovasc Dis 2014; 23: 1690-5.
44. Thaler DE, Ruthazer R, Di Angelantonio E, et al. Neuroimaging findings in cryptogenic stroke patients with and without patent foramen ovale. Stroke 2013; 44: 675-80.
45. Kent DM, Dahabreh IJ, Ruthazer R, et al. Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis. Eur Heart J 2015; 36: 2381-9.
46. Kitsios GD, Dahabreh IJ, Abu Dabrh AM, Thaler DE, Kent DM. Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence. Stroke 2012; 43: 422-31.
47. Hornung M, Bertog SC, Franke J, et al. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale. Eur Heart J 2013; 34: 3362-9.
48. Meier B, Kalesan B, Mattle HP, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 2013; 368: 1083-91.
49. Furlan AJ, Reisman M, Massaro J, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 2012; 366: 991-9.
50. Kent DM, Dahabreh IJ, Ruthazer R, et al. Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials. J Am Coll Cardiol 2016; 67: 907-17.
51. Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 2160-236.
52. Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870-947.
53. Culebras A, Messé SR, Chaturvedi S, Kase CS, Gronseth G. Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2014; 82: 716-24.
54. Singhal AB, Biller J, Elkind MS, et al. Recognition and management of stroke in young adults and adolescents. Neurology 2013; 81: 1089-97.